|Articles|January 31, 2022
ROI of ePRO Use in Clinical Trials
Author(s)Datacubed Health
The cost and benefits for patients and sponsors in using ePRO versus paper
Related Content
Trending on Applied Clinical Trials Online
1
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
2
ACT Brief: FDA CRL Transparency Pause, Protocol-Centric Recruitment Model Shift, and Medical Affairs Integration in Development
3
ACT Brief: Portfolio-Level Recruitment Strategy, Real-Time Burden Sampling, and Platinum-Free Bladder Cancer Therapy
4
Before Burden Becomes Risk: Capturing Friction in Real Time
5